FOLH1 and neuroendocrine carcinoma: More recently, Chang et al [19] examined multiple anti-PSMA antibodies and showed that each antibody consistently bound the tumor-associated neovasculature in cases of testicular embryonal carcinoma, neuroendocrine carcinoma, malignant skin melanoma, pancreatic duct carcinoma, non-small cell lung carcinoma, soft tissue sarcoma, and breast carcinoma.